0001493152-23-032280.txt : 20230911 0001493152-23-032280.hdr.sgml : 20230911 20230911171805 ACCESSION NUMBER: 0001493152-23-032280 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230907 FILED AS OF DATE: 20230911 DATE AS OF CHANGE: 20230911 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BUCHAN MELISSA JANE CENTRAL INDEX KEY: 0001342502 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41159 FILM NUMBER: 231248483 MAIL ADDRESS: STREET 1: 1920 MAIN STREET STREET 2: SUITE 500 CITY: IRVINE STATE: CA ZIP: 92614 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Immix Biopharma, Inc. CENTRAL INDEX KEY: 0001873835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 454869378 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11400 WEST OLYMPIC BLVD. STREET 2: SUITE 200 CITY: LOS ANGELES STATE: CA ZIP: 90064 BUSINESS PHONE: (888) 958-1084 MAIL ADDRESS: STREET 1: 10573 W. PICO BLVD. STREET 2: #58 CITY: LOS ANGELES STATE: CA ZIP: 90064 4 1 ownership.xml X0508 4 2023-09-07 0 0001873835 Immix Biopharma, Inc. IMMX 0001342502 BUCHAN MELISSA JANE C/O IMMIX BIOPHARMA, INC. 11400 WEST OLYMPIC BLVD., SUITE 200 LOS ANGELES CA 90064 1 0 0 0 0 Common Stock 2023-09-07 4 P 0 20000 2.4613 A 20000 D This figure is the weighted average sales price of multiple trades ranging from $2.39 to $2.49 per share. The Reporting Person undertakes to provide the staff of the Securities and Exchange Commission, Immix Biopharma, Inc. or any security holder of Immix Biopharma, Inc. full information about the number of shares sold at each separate price upon request. /s/ Ilya Rachman as Attorney-In-Fact for Jane Buchan 2023-09-11